Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Paratek Pharmaceuticals, Inc. | d8k.htm |
Exhibit 99.1
CAMILLE D. SAMUELS
January 21, 2011
G. Kirk Raab
Chairman of the Board of Directors
and
Glenn A. Oclassen
President and Chief Executive Officer
Transcept Pharmaceuticals, Inc.
1003 W. Cutting Blvd., Suite 110
Pt. Richmond, CA 94804
Dear Kirk and Glenn:
I hereby resign from the Board of Directors of Transcept Pharmaceuticals, Inc. effective immediately after the 2011 annual stockholders’ meeting.
I trust my resignation will provide the Board with flexibility given the recognition that the number of board members should be reduced and the changing expertise required as the company develops toward commercialization capabilities.
It is a pleasure working with you and the other members of the Transcept Board. I believe that under your leadership the anticipated value drivers that were envisioned at the time of our merger will be fully realized.
| Sincerely, |
| /s/ Camille D. Samuels |
| Camille D. Samuels |